Moxifloxacin Pharmaceutical Grade Respiratory Tract Infections

China Moxifloxacin Pharmaceutical Grade Respiratory Tract Infections, Find details about China Moxifloxacin, API from Moxifloxacin Pharmaceutical Grade Respiratory Tract Infections

Model NO.
pharmaceutical grade
Pharmaceutical Technology
Chemical Synthesis
Production Line
GMP Approved
Transport Package
Drums
Specification
25kg/drum
Origin
Hebei
HS Code
3004909099
Model NO.
pharmaceutical grade
Pharmaceutical Technology
Chemical Synthesis
Production Line
GMP Approved
Transport Package
Drums
Specification
25kg/drum
Origin
Hebei
HS Code
3004909099
Moxifloxacin
 
Product name: Moxifloxacin
Indication: upper and lower respiratory tract infections, such as acute sinusitis, acute episodes of chronic bronchitis, and community-acquired pneumonia;And skin and soft tissue infections.Complex abdominal infections include mixed bacterial infections such as abscesses.

SSY Group Limited, established in 1948, principally specializes in R&D, manufacture, and sale of a widerange of pharmaceutical products, including various dosage forms such as intravenous injections, tablets, capsule, ampoules, APIs and medical packaging materials.The main subsidiaries of SSY are as follows
Shijiazhuang No 4 Pharmaceutical Co, Ltd
Hebei Guangxiang Pharmaceutical Co, Ltd.
Hebei Guolong Pharmaceutical Co, Ltd
Jiangsu Best New Medical Material Co, Ltd.
With more than 70-year development, our products
have been sold to both domestic and overseas
markets up to more than 80 countries and regions. 


Hebei Guolong Pharmaceutical Co, Ltd, is a professional manufacturer, which is a wholly owned
subsidiary of SSY GROUP. It possess advanced equipment and leading technology with excellent
management, locates in Shijiazhuang Economic and Technological Development Zone, and specializes in manufacturing Active Pharmaceutical Ingredients such as Azithromycin,  Moxifloxacin HCL, Arbidol Hydrochloride, Bromhexine Hydrochloride etc.


Moxifloxacin Pharmaceutical Grade Respiratory Tract Infections